Employing pancreatic tumor γ-glutamyltransferase for therapeutic delivery

Molecular Pharmaceutics

Volumn 11, Issue 5, 2014, Pages 1500-1511

  Ramsay, Emma E ^a   Decollogne, Stéphanie ^a   Joshi, Swapna ^a   Corti, Alessandro ^b   Apte, Minoti ^c   Pompella, Alfonso ^b   Hogg, Philip J ^a   Dilda, Pierre J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

pancreatic cancer; prodrug; stellate cells; glutamyltransferase

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; ORGANOARSENIC DERIVATIVE; DRUG CARRIER; PRODRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; HUMAN CELL; MITOCHONDRION; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREATIC STELLATE CELL; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VASCULARIZATION; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CELL LINE; CHEMISTRY; FEMALE; IN VITRO STUDY; METABOLISM; PANCREATIC NEOPLASMS;

ANIMALS; ARSENICALS; CELL LINE; DRUG CARRIERS; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GLUTATHIONE; HUMANS; IN VITRO TECHNIQUES; MICE; MICE, INBRED BALB C; PANCREATIC NEOPLASMS; PRODRUGS;

EID: 84899865143     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400664t     Document Type: Article

References (44)

1. Simon, R. Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology Pers. Med. 2010, 7 (1) 33-47
2. Apte, M. V.; Wilson, J. S. Dangerous liaisons: pancreatic stellate cells and pancreatic cancer cells J. Gastroenterol. Hepatol. 2012, 27 (Suppl. 2) 69-74
3. Apte, M. V.; Park, S.; Phillips, P. A.; Santucci, N.; Goldstein, D.; Kumar, R. K.; Ramm, G. A.; Buchler, M.; Friess, H.; McCarroll, J. A.; Keogh, G.; Merrett, N.; Pirola, R.; Wilson, J. S. Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells Pancreas 2004, 29 (3) 179-87
4. Apte, M. V.; Wilson, J. S.; Lugea, A.; Pandol, S. J. A starring role for stellate cells in the pancreatic cancer microenvironment Gastroenterology 2013, 144 (6) 1210-9
5. Xu, Z.; Vonlaufen, A.; Phillips, P. A.; Fiala-Beer, E.; Zhang, X.; Yang, L.; Biankin, A. V.; Goldstein, D.; Pirola, R. C.; Wilson, J. S.; Apte, M. V. Role of pancreatic stellate cells in pancreatic cancer metastasis Am. J. Pathol. 2010, 177 (5) 2585-96
6. Korc, M. Pancreatic cancer-associated stroma production Am. J. Surg. 2007, 194 (4 Suppl.) S84-6
7. Hanigan, M. H.; Frierson, H. F., Jr.; Swanson, P. E.; De Young, B. R. Altered expression of gamma-glutamyl transpeptidase in human tumors Hum. Pathol. 1999, 30 (3) 300-5
8. Franzini, M.; Corti, A.; Lorenzini, E.; Paolicchi, A.; Pompella, A.; De Cesare, M.; Perego, P.; Gatti, L.; Leone, R.; Apostoli, P.; Zunino, F. Modulation of cell growth and cisplatin sensitivity by membrane gamma-glutamyltransferase in melanoma cells Eur. J. Cancer 2006, 42 (15) 2623-30
9. Daubeuf, S.; Balin, D.; Leroy, P.; Visvikis, A. Different mechanisms for gamma-glutamyltransferase-dependent resistance to carboplatin and cisplatin Biochem. Pharmacol. 2003, 66 (4) 595-604
10. Hector, S.; Nava, M. E.; Clark, K.; Murphy, M.; Pendyala, L. Characterization of a clonal isolate of an oxaliplatin resistant ovarian carcinoma cell line A2780/C10 Cancer Lett. 2007, 245 (1-2) 195-204
11. Pompella, A.; De Tata, V.; Paolicchi, A.; Zunino, F. Expression of gamma-glutamyltransferase in cancer cells and its significance in drug resistance Biochem. Pharmacol. 2006, 71 (3) 231-8
12. Huseby, N. E.; Stromme, J. H. Practical points regarding routine determination of gamma-glutamyl transferase (gamma-GT) in serum with a kinetic method at 37 degrees C Scand. J. Clin. Lab. Invest. 1974, 34 (4) 357-63
13. Donoghue, N.; Yam, P. T.; Jiang, X. M.; Hogg, P. J. Presence of closely spaced protein thiols on the surface of mammalian cells Protein Sci. 2000, 9 (12) 2436-45
14. Antczak, C.; Karp, D. R.; London, R. E.; Bauvois, B. Reanalysis of the involvement of gamma-glutamyl transpeptidase in the cell activation process FEBS Lett. 2001, 508 (2) 226-30
15. Vonlaufen, A.; Phillips, P. A.; Yang, L.; Xu, Z.; Fiala-Beer, E.; Zhang, X.; Pirola, R. C.; Wilson, J. S.; Apte, M. V. Isolation of quiescent human pancreatic stellate cells: a promising in vitro tool for studies of human pancreatic stellate cell biology Pancreatology 2010, 10 (4) 434-43
16. Tseng, J. C.; Granot, T.; DiGiacomo, V.; Levin, B.; Meruelo, D. Enhanced specific delivery and targeting of oncolytic Sindbis viral vectors by modulating vascular leakiness in tumor Cancer Gene Ther. 2010, 17 (4) 244-55
17. Bissery, M. C.; Guenard, D.; Gueritte-Voegelein, F.; Lavelle, F. Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a Taxol analogue Cancer Res. 1991, 51 (18) 4845-52
18. Dilda, P. J.; Decollogne, S.; Weerakoon, L.; Norris, M. D.; Haber, M.; Allen, J. D.; Hogg, P. J. Optimization of the antitumor efficacy of a synthetic mitochondrial toxin by increasing the residence time in the cytosol J. Med. Chem. 2009, 52 (20) 6209-16
19. Dilda, P. J.; Ramsay, E. E.; Corti, A.; Pompella, A.; Hogg, P. J. Metabolism of the tumor angiogenesis inhibitor 4-(N-(S-Glutathionylacetyl)amino) phenylarsonous acid J. Biol. Chem. 2008, 283 (51) 35428-34
20. Don, A. S.; Kisker, O.; Dilda, P.; Donoghue, N.; Zhao, X.; Decollogne, S.; Creighton, B.; Flynn, E.; Folkman, J.; Hogg, P. J. A peptide trivalent arsenical inhibits tumor angiogenesis by perturbing mitochondrial function in angiogenic endothelial cells Cancer Cell 2003, 3 (5) 497-509
21. Dilda, P. J.; Decollogne, S.; Rossiter-Thornton, M.; Hogg, P. J. Para to ortho repositioning of the arsenical moiety of the angiogenesis inhibitor 4-(N-(S-glutathionylacetyl)amino)phenylarsenoxide results in a markedly increased cellular accumulation and antiproliferative activity Cancer Res. 2005, 65 (24) 11729-34
22. Dilda, P. J.; Don, A. S.; Tanabe, K. M.; Higgins, V. J.; Allen, J. D.; Dawes, I. W.; Hogg, P. J. Mechanism of selectivity of an angiogenesis inhibitor from screening a genome-wide set of Saccharomyces cerevisiae deletion strains J. Natl. Cancer Inst. 2005, 97 (20) 1539-47
23. Strebel, A.; Harr, T.; Bachmann, F.; Wernli, M.; Erb, P. Green fluorescent protein as a novel tool to measure apoptosis and necrosis Cytometry 2001, 43 (2) 126-33
24. Steff, A. M.; Fortin, M.; Arguin, C.; Hugo, P. Detection of a decrease in green fluorescent protein fluorescence for the monitoring of cell death: an assay amenable to high-throughput screening technologies Cytometry 2001, 45 (4) 237-43
25. Modzelewski, R. A.; Davies, P.; Watkins, S. C.; Auerbach, R.; Chang, M. J.; Johnson, C. S. Isolation and identification of fresh tumor-derived endothelial cells from a murine RIF-1 fibrosarcoma Cancer Res. 1994, 54 (2) 336-9
26. Hidalgo, M. Pancreatic cancer N. Engl. J. Med. 2010, 362 (17) 1605-17
27. Whitfield, J. B. Gamma glutamyl transferase Crit. Rev. Clin. Lab. Sci. 2001, 38 (4) 263-355
28. D'Assignies, G.; Couvelard, A.; Bahrami, S.; Vullierme, M. P.; Hammel, P.; Hentic, O.; Sauvanet, A.; Bedossa, P.; Ruszniewski, P.; Vilgrain, V. Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors Radiology 2009, 250 (2) 407-16
29. Porta, M.; Pumarega, J.; Guarner, L.; Malats, N.; Sola, R.; Real, F. X.; Group, P. I. S. Relationships of hepatic and pancreatic biomarkers with the cholestatic syndrome and tumor stage in pancreatic cancer Biomarkers 2012, 17 (6) 557-65
30. Bachem, M. G.; Schunemann, M.; Ramadani, M.; Siech, M.; Beger, H.; Buck, A.; Zhou, S.; Schmid-Kotsas, A.; Adler, G. Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells Gastroenterology 2005, 128 (4) 907-21
31. Abdollahi, A.; Schwager, C.; Kleeff, J.; Esposito, I.; Domhan, S.; Peschke, P.; Hauser, K.; Hahnfeldt, P.; Hlatky, L.; Debus, J.; Peters, J. M.; Friess, H.; Folkman, J.; Huber, P. E. Transcriptional network governing the angiogenic switch in human pancreatic cancer Proc. Natl. Acad. Sci. U.S.A. 2007, 104 (31) 12890-5
32. Ikenaga, N.; Ohuchida, K.; Mizumoto, K.; Cui, L.; Kayashima, T.; Morimatsu, K.; Moriyama, T.; Nakata, K.; Fujita, H.; Tanaka, M. CD10+ pancreatic stellate cells enhance the progression of pancreatic cancer Gastroenterology 2010, 139 (3) 1041-51
33. Vonlaufen, A.; Phillips, P. A.; Xu, Z.; Goldstein, D.; Pirola, R. C.; Wilson, J. S.; Apte, M. V. Pancreatic stellate cells and pancreatic cancer cells: an unholy alliance Cancer Res. 2008, 68 (19) 7707-10
34. Park, D.; Chiu, J.; Perrone, G. G.; Dilda, P. J.; Hogg, P. J. The tumour metabolism inhibitors GSAO and PENAO react with cysteines 57 and 257 of mitochondrial adenine nucleotide translocase Cancer Cell Int. 2012, 12 (1) 11
35. Halestrap, A. P.; McStay, G. P.; Clarke, S. J. The permeability transition pore complex: another view Biochimie 2002, 84 (2-3) 153-66
36. Halestrap, A. P. What is the mitochondrial permeability transition pore? J. Mol. Cell. Cardiol. 2009, 46 (6) 821-31
37. Bellini, M.; Tumino, E.; Giordani, R.; Fabrini, G.; Costa, F.; Galli, R.; Rucco, M.; Belcari, C.; Michelassi, C.; Murri, L.; Maltinti, G.; Marchi, S. Serum gamma-glutamyl-transpeptidase isoforms in alcoholic liver disease Alcohol Alcohol. 1997, 32 (3) 259-66
38. Schiele, F.; Guilmin, A. M.; Detienne, H.; Siest, G. Gamma- glutamyltransferase activity in plasma: statistical distributions, individual variations, and reference intervals Clin. Chem. 1977, 23 (6) 1023-8
39. Anders, M. W. Chemical toxicology of reactive intermediates formed by the glutathione-dependent bioactivation of halogen-containing compounds Chem. Res. Toxicol. 2008, 21 (1) 145-59
40. Enoiu, M.; Herber, R.; Wennig, R.; Marson, C.; Bodaud, H.; Leroy, P.; Mitrea, N.; Siest, G.; Wellman, M. gamma-Glutamyltranspeptidase-dependent metabolism of 4-hydroxynonenal-glutathione conjugate Arch. Biochem. Biophys. 2002, 397 (1) 18-27
41. Hanigan, M. H.; Townsend, D. M.; Cooper, A. J. Metabolism of cisplatin to a nephrotoxin Toxicology 2009, 257 (3) 174-5
42. Wainford, R. D.; Weaver, R. J.; Stewart, K. N.; Brown, P.; Hawksworth, G. M. Metabolism of cisplatin to a nephrotoxin [Toxicology, 257(3), 174-175, doi 10.1016/j.tox.2008.12.014] Toxicology 2009, 257 (3) 176-7
43. Drieman, J. C.; Thijssen, H. H.; Struyker-Boudier, H. A. Renal selective N-acetyl-gamma-glutamyl prodrugs. II. Carrier-mediated transport and intracellular conversion as determinants in the renal selectivity of N-acetyl-gamma-glutamyl sulfamethoxazole J. Pharmacol. Exp. Ther. 1990, 252 (3) 1255-60
44. Drieman, J. C.; Thijssen, H. H.; Struyker-Boudier, H. A. Renal selective N-acetyl-L-gamma-glutamyl prodrugs: studies on the selectivity of some model prodrugs Br. J. Pharmacol. 1993, 108 (1) 204-8